You have 9 free searches left this month | for more free features.

cell dose

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liquid Biopsy Diagnostic Techniques for Endometriosis

Recruiting
  • Liquid Biopsy
  • Endometriosis
  • Three-Dimensional Poly(dimethylsiloxane) Scaffold
  • Wuhan, Hubei, China
    Wenwen Wang
Feb 18, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, MY008211A tablets matched )

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • MY008211A tablets
  • MY008211A tablets matched placebo
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Apr 13, 2023

Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)

Completed
  • Head and Neck Squamous Cell Cancer
  • INO-3112
  • CELLECTRA™-5P
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 4, 2021

Diabetes, Type 1 Trial in Dresden, München (intranasal insulin, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • intranasal insulin
  • Placebo
  • Dresden, Germany
  • +1 more
Jun 21, 2021

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Healthy Volunteer, Dry Age-related Macular Degeneration Trial (Tinlarebant (LBS-008))

Not yet recruiting
  • Healthy Volunteer
  • Dry Age-related Macular Degeneration
  • Tinlarebant (LBS-008)
  • (no location specified)
Dec 19, 2022

Solid Tumor Trial in Belgium, Netherlands (INT-1B3)

Recruiting
  • Solid Tumor
  • Brussels, Wallonie, Belgium
  • +3 more
Feb 4, 2022

Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

Not yet recruiting
  • Psoriasis Vulgaris
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)

Completed
  • Lymphoma
  • AMG 531
  • +8 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 25, 2021

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Hepatocellular Carcinoma Trial in China (CAR-GPC3 T Cells)

Completed
  • Hepatocellular Carcinoma
  • CAR-GPC3 T Cells
  • Guangzhou, Guangdong, China
  • +5 more
Feb 8, 2022

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Plantar Wart Trial (intralesional combined digoxin and furosemide, intralesional injection of 5- Fluorouracil, intralesional

Not yet recruiting
  • Plantar Wart
  • intralesional combined digoxin and furosemide
  • +2 more
  • (no location specified)
Oct 25, 2022

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022

Smallpox Trial in Overland Park (Brincidofovir)

Recruiting
  • Smallpox
  • Overland Park, Kansas
    Altasciences
Jul 5, 2023

Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

Recruiting
  • Anemia in Dialysis-dependent CKD Patients
  • Alexandria, Egypt
    Alexandria University
Oct 29, 2023

Head Neck Cancer Trial in London (Intra-tumoral T4 immunotherapy)

Recruiting
  • Head and Neck Cancer
  • Intra-tumoral T4 immunotherapy
  • London, United Kingdom
    Clinical Research Facility, Guy's Hospital
Mar 28, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (Oral Azacitidine, Rituximab, cyclophosphamide)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Follicular
  • Oral Azacitidine
  • +4 more
  • Tampa, Florida
  • +6 more
Aug 26, 2020

Cytomegalovirus Infections Trial (V160 Low Dose IM, V160 Medium Dose IM, V160 High Dose IM)

Completed
  • Cytomegalovirus Infections
  • V160 Low Dose IM
  • +8 more
  • (no location specified)
Sep 30, 2021

Coronavirus Disease 2019 (COVID-19), Healthy Volunteer Trial in Guangzhou, Shanghai (AZD7442 IM, Placebo IM, AZD7442 IV)

Active, not recruiting
  • Coronavirus Disease 2019 (COVID-19)
  • Healthy Volunteer
  • AZD7442 IM
  • +3 more
  • Guangzhou, China
  • +1 more
Jul 27, 2022

Obinutuzumab in Chinese Real-world Patients With iNHL

Not yet recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Changzhou, Jiangsu, China
  • +24 more
Jul 23, 2023